{"id":740262,"date":"2023-03-15T08:39:51","date_gmt":"2023-03-15T12:39:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/"},"modified":"2023-03-15T08:39:51","modified_gmt":"2023-03-15T12:39:51","slug":"reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/","title":{"rendered":"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN CLEMENTE, Calif., March  15, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3Ijx2412EGtxQ8pUJmANP8WyCULZRu4PQ_z5g9lT6vtgT-q5qSmxQrFR3SN29EpWuhB6wgPSuZE40xrYaRDe5ZEbaTFPy1hIXhpjmm1_Fhs=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>ReShape Lifesciences<\/strong><\/a><strong> Inc. (Nasdaq: RSLS), <\/strong>the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview at the Q2 Virtual Investor Summit on Wednesday, March 29 at 1:00 pm ET. During the virtual presentation, management will highlight the Company\u2019s three pillars for growth and its portfolio of products that address the entire weight loss continuum including the anatomy-sparing Lap-Band<sup>\u00ae<\/sup>.<\/p>\n<p align=\"justify\">ReShape Lifesciences\u2019 management team will be available for one-on-one meetings during the Investor Summit. The conference is complimentary to qualified investors. Please register through the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ae1KA-9bCh1NXwLbHmQbNXp6sX_8VnisQfSru9emEoN05Tr72ZSg2GGjikDCzPLOMeWhMBKxoUi1e6Gy2yYajwaJiKbwk6Fs6Uyts4ZnEqpnvcQ7s3wVHxZOUwHaM5769qr5HwdHOqqMG2hBnjkyfZlB6jStsbfEUfIrLM9hMxwoT7JWBE4Cn9LCcg1s1zXl-IgpjqM35xUh4CcG4dHSRQ==\" rel=\"nofollow noopener\" target=\"_blank\">Complimentary Investor Registration<\/a>. To schedule a meeting with management outside of the conference, contact Michael Miller with Rx Communications at mmiller@rxir.com.<\/p>\n<p align=\"justify\">A live webcast of the Investor Summit presentation will be available on the \u201cEvents and Presentations\u201d section of ReShape\u2019s website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D2G50agbRBYeii22-bbti4qCh7V2wjc0hI4jgVLdIllU1qFRNADYGfYbcLP_2HdKRtuAskqQ0y3557r1vVWr7Y1oZDzicPW-0pTsE6PdI6c9cHEC_2uJo4VxdevJiaNa-KgUr--G-A65HBq2jEIJ-ZWkzcG1oWtgyAYPaYd0YbxAeVxLZa6M9Lkv3JqDfYYx\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.reshapelifesciences.com\/events-and-presentations<\/a>. An archived replay will be available on the company\u2019s website for a period of 90 days after the conference.<\/p>\n<p align=\"justify\">\n        <strong>About ReShape Lifesciences Inc.<\/strong><br \/>\n        <br \/>ReShape Lifesciences<sup>\u00ae<\/sup> is America\u2019s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The proprietary, FDA-approved, Lap-Band<sup>\u00ae<\/sup> Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. ReShapeCare\u2122 is a virtual weight-management program that supports lifestyle changes for all weight loss patients led by board-certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace\u2122 is an online collection of quality wellness products curated for all consumers to help them achieve their health goals. The investigational Diabetes Bloc-Stim Neuromodulation\u2122 (DBSN\u2122) system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of Type 2 diabetes and metabolic disorders. The patented, Obalon\u00ae balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qpd7icLByvTxDj8Qw_-tOqqYFVl3mj02EQ1CehWY7OdwXG37w1DTqYrotEKF1xAIH0yTWPtXKhp7yNULQ9CDz3T1VpJh1MQU8td13d6bFiTdT8xVqkmwKrjqZK__5BnvWQ30px4TGAbLIUuIUaxl-N6WAZkEZ0pJdAmaX-hd4TXscEOW4SA5s-c1DEejS0I9H-8wHRAuYbOMn61OK_SObgnCVZ1ibRtJTJzKRia5Mzz3xqBEQFLJAsPN0O8YI08JtuEJn8K_bhPpnWrGk69a5_vUJDTXUupPUm0zC-Iuswg=\" rel=\"nofollow noopener\" target=\"_blank\">www.reshapelifesciences.com<\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>ReShape Lifesciences Investor Contact:<\/strong><br \/>\n        <br \/>Thomas Stankovich<br \/>Chief Financial Officer<br \/>949-276-6042<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UTn7rKuhL5F2MTln-L3-cZz5hnTHD72uu8SL0ZPHDZz3FEtzRLog9jOQEHSAhQ-8RWjE8BCXJ6RTmrsDAgPCKyaLQKlYsL_D02VDWa2lbCZqDdeGtKj-sKCP2AbjZ6TpK3UtiUIUcacFlzK5MhdgNGaRrNBQsEXADE2Ss8-FlpgTO8QWeqzKytIYWskkMBuFfTetyngzCkHL7jWdrW7PTzvT8oHK87lqtgZyKLa5M6DOIht7spmInpXt5G9TYUWzESBigI4vDobre5lbgrSYWg==\" rel=\"nofollow noopener\" target=\"_blank\">ir@ReShapeLifesci.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Rx Communications Group<br \/>Michael Miller<br \/>(917)-633-6086<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8gpBOFxohf8OOI87NtQnpJ3U-dHbNf1MxmusNsAZmcxYArnU3URmTuh4ukdv2ZSOq6aUth03r-CtlVbBHg64-Q==\" rel=\"nofollow noopener\" target=\"_blank\">mmiller@rxir.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjYzNDhiZjUtZWJhMS00NjczLThiYjQtZmIzNjIyODQ3MGRhLTEwMTg2NDU=\/tiny\/ReShape-Lifesciences-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview at the Q2 Virtual Investor Summit on Wednesday, March 29 at 1:00 pm ET. During the virtual presentation, management will highlight the Company\u2019s three pillars for growth and its portfolio of products that address the entire weight loss continuum including the anatomy-sparing Lap-Band\u00ae. ReShape Lifesciences\u2019 management team will be available for one-on-one meetings during the Investor Summit. The conference is complimentary to qualified investors. Please register through the Complimentary Investor Registration. To schedule a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740262","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview at the Q2 Virtual Investor Summit on Wednesday, March 29 at 1:00 pm ET. During the virtual presentation, management will highlight the Company\u2019s three pillars for growth and its portfolio of products that address the entire weight loss continuum including the anatomy-sparing Lap-Band\u00ae. ReShape Lifesciences\u2019 management team will be available for one-on-one meetings during the Investor Summit. The conference is complimentary to qualified investors. Please register through the Complimentary Investor Registration. To schedule a &hellip; Continue reading &quot;ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-15T12:39:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit\",\"datePublished\":\"2023-03-15T12:39:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/\",\"name\":\"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=\",\"datePublished\":\"2023-03-15T12:39:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/","og_locale":"en_US","og_type":"article","og_title":"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit - Market Newsdesk","og_description":"SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview at the Q2 Virtual Investor Summit on Wednesday, March 29 at 1:00 pm ET. During the virtual presentation, management will highlight the Company\u2019s three pillars for growth and its portfolio of products that address the entire weight loss continuum including the anatomy-sparing Lap-Band\u00ae. ReShape Lifesciences\u2019 management team will be available for one-on-one meetings during the Investor Summit. The conference is complimentary to qualified investors. Please register through the Complimentary Investor Registration. To schedule a &hellip; Continue reading \"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-15T12:39:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit","datePublished":"2023-03-15T12:39:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/"},"wordCount":386,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/","name":"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=","datePublished":"2023-03-15T12:39:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwOSM1NDYyMzIyIzIwMDcwNzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-to-present-at-the-q2-virtual-investor-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ReShape Lifesciences\u00ae to Present at the Q2 Virtual Investor Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740262"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740262\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}